1 Community Heart Failure Program, Department of Cardiology, Bellvitge University Hospital, 19th Floor. Feixa Llarga s/n, L'Hospitalet de Llobregat, Barcelona 08907, Spain; Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain; Cardio-Oncology Unit, Cardiology Department, Bellvitge University Hospital and Catalan Institute of Oncology (ICO), L'Hospital de Llobregat, Barcelona, Spain. Electronic address: rramosp@bellvitgehospital.cat.
2 Community Heart Failure Program, Department of Cardiology, Bellvitge University Hospital, 19th Floor. Feixa Llarga s/n, L'Hospitalet de Llobregat, Barcelona 08907, Spain; Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain; Cardio-Oncology Unit, Cardiology Department, Bellvitge University Hospital and Catalan Institute of Oncology (ICO), L'Hospital de Llobregat, Barcelona, Spain; Department of Clinical Sciences, School of Medicine, University of Barcelona, Barcelona, Spain. Electronic address: pmoliner@bellvitgehospital.cat.
3 Community Heart Failure Program, Department of Cardiology, Bellvitge University Hospital, 19th Floor. Feixa Llarga s/n, L'Hospitalet de Llobregat, Barcelona 08907, Spain; Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain; Department of Clinical Sciences, School of Medicine, University of Barcelona, Barcelona, Spain. Electronic address: josepcomin@gmail.com.